

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.99879622 |
| 2 | negative T cell selection (GO:0043383) | 6.87758349 |
| 3 | activated T cell proliferation (GO:0050798) | 6.46889422 |
| 4 | tolerance induction (GO:0002507) | 6.13578866 |
| 5 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.06736782 |
| 6 | negative thymic T cell selection (GO:0045060) | 6.02660848 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.92844841 |
| 8 | negative regulation of cell killing (GO:0031342) | 5.92121387 |
| 9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.92121387 |
| 10 | positive T cell selection (GO:0043368) | 5.71901576 |
| 11 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.61667982 |
| 12 | thymic T cell selection (GO:0045061) | 5.44468559 |
| 13 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.43942167 |
| 14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.41481832 |
| 15 | T cell migration (GO:0072678) | 5.39747593 |
| 16 | T cell selection (GO:0045058) | 5.38694071 |
| 17 | regulation of regulatory T cell differentiation (GO:0045589) | 5.35267193 |
| 18 | regulation of T cell tolerance induction (GO:0002664) | 5.04242521 |
| 19 | positive thymic T cell selection (GO:0045059) | 5.01816928 |
| 20 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.95824345 |
| 21 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.93915827 |
| 22 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.85259273 |
| 23 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.77437474 |
| 24 | response to interleukin-15 (GO:0070672) | 4.65641907 |
| 25 | cellular response to interleukin-15 (GO:0071350) | 4.64805704 |
| 26 | positive regulation of tolerance induction (GO:0002645) | 4.50397949 |
| 27 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.48417193 |
| 28 | regulation of gamma-delta T cell activation (GO:0046643) | 4.45618436 |
| 29 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.38174560 |
| 30 | T cell receptor signaling pathway (GO:0050852) | 4.32592133 |
| 31 | regulation of tolerance induction (GO:0002643) | 4.20417607 |
| 32 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.13931510 |
| 33 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.99512183 |
| 34 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.96722801 |
| 35 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.93253526 |
| 36 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.87026554 |
| 37 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.85785135 |
| 38 | leukocyte aggregation (GO:0070486) | 3.82166030 |
| 39 | interferon-gamma production (GO:0032609) | 3.74733300 |
| 40 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.72956514 |
| 41 | alpha-beta T cell differentiation (GO:0046632) | 3.69773063 |
| 42 | positive regulation of granulocyte differentiation (GO:0030854) | 3.63672399 |
| 43 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.62447745 |
| 44 | regulation of chronic inflammatory response (GO:0002676) | 3.57592484 |
| 45 | positive regulation of humoral immune response (GO:0002922) | 3.57347743 |
| 46 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.55967241 |
| 47 | regulation of B cell differentiation (GO:0045577) | 3.54466343 |
| 48 | negative regulation of T cell mediated immunity (GO:0002710) | 3.53320464 |
| 49 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.52739078 |
| 50 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.50003364 |
| 51 | cytolysis (GO:0019835) | 3.49001092 |
| 52 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.48196277 |
| 53 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.47574980 |
| 54 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.47370607 |
| 55 | alpha-beta T cell activation (GO:0046631) | 3.47127871 |
| 56 | cellular response to type I interferon (GO:0071357) | 3.45666208 |
| 57 | type I interferon signaling pathway (GO:0060337) | 3.45666208 |
| 58 | response to type I interferon (GO:0034340) | 3.43411058 |
| 59 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.41722745 |
| 60 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.41722745 |
| 61 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.41408317 |
| 62 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.40226146 |
| 63 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.40226146 |
| 64 | modulation by symbiont of host immune response (GO:0052553) | 3.40226146 |
| 65 | positive regulation by symbiont of host defense response (GO:0052509) | 3.40226146 |
| 66 | modulation by symbiont of host defense response (GO:0052031) | 3.40226146 |
| 67 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.40226146 |
| 68 | purine-containing compound salvage (GO:0043101) | 3.39718766 |
| 69 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.39236167 |
| 70 | regulation of alpha-beta T cell activation (GO:0046634) | 3.38090955 |
| 71 | T cell homeostasis (GO:0043029) | 3.37145668 |
| 72 | positive regulation of interleukin-2 production (GO:0032743) | 3.35390615 |
| 73 | positive regulation of B cell differentiation (GO:0045579) | 3.33787539 |
| 74 | positive regulation of alpha-beta T cell activation (GO:0046635) | 3.33397459 |
| 75 | T cell costimulation (GO:0031295) | 3.30467201 |
| 76 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.29858082 |
| 77 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 3.28913855 |
| 78 | lymphocyte migration (GO:0072676) | 3.27844675 |
| 79 | lymphocyte costimulation (GO:0031294) | 3.26630178 |
| 80 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.24700947 |
| 81 | positive regulation of interleukin-4 production (GO:0032753) | 3.20845945 |
| 82 | positive regulation of cell killing (GO:0031343) | 3.19126557 |
| 83 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 3.14835118 |
| 84 | regulation of defense response to virus by host (GO:0050691) | 3.14185883 |
| 85 | mast cell activation (GO:0045576) | 3.13901283 |
| 86 | positive regulation of alpha-beta T cell differentiation (GO:0046638) | 3.10378928 |
| 87 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.06862642 |
| 88 | regulation of cell killing (GO:0031341) | 3.04843458 |
| 89 | cytidine metabolic process (GO:0046087) | 3.02335367 |
| 90 | cytidine catabolic process (GO:0006216) | 3.02335367 |
| 91 | cytidine deamination (GO:0009972) | 3.02335367 |
| 92 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.01564732 |
| 93 | actin nucleation (GO:0045010) | 3.01407603 |
| 94 | T cell differentiation (GO:0030217) | 3.00129185 |
| 95 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.98022053 |
| 96 | detection of bacterium (GO:0016045) | 2.96526000 |
| 97 | positive regulation of T cell mediated immunity (GO:0002711) | 2.96352476 |
| 98 | regulation of alpha-beta T cell differentiation (GO:0046637) | 2.95922104 |
| 99 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.95303960 |
| 100 | B cell receptor signaling pathway (GO:0050853) | 2.91267386 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 7.41763998 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.97085864 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.96635080 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.34399740 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.17488955 |
| 6 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.88257278 |
| 7 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.80148022 |
| 8 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.63766415 |
| 9 | MYB_26560356_Chip-Seq_TH2_Human | 3.52250289 |
| 10 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.51652352 |
| 11 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.32551137 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.27046851 |
| 13 | MAF_26560356_Chip-Seq_TH1_Human | 3.11797499 |
| 14 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.10153684 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.03391421 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.02106629 |
| 17 | UTX_26944678_Chip-Seq_JUKART_Human | 2.84851165 |
| 18 | MYB_26560356_Chip-Seq_TH1_Human | 2.74927873 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.74205239 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.48433108 |
| 21 | MAF_26560356_Chip-Seq_TH2_Human | 2.34134788 |
| 22 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.23013300 |
| 23 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.14304515 |
| 24 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.13814199 |
| 25 | MYC_22102868_ChIP-Seq_BL_Human | 2.13656549 |
| 26 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.11327042 |
| 27 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.09503082 |
| 28 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.06803070 |
| 29 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.96927964 |
| 30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.93807838 |
| 31 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.80908739 |
| 32 | GATA3_26560356_Chip-Seq_TH2_Human | 1.74410518 |
| 33 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.70885936 |
| 34 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.67965099 |
| 35 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64203575 |
| 36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61475199 |
| 37 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.60877059 |
| 38 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.54193395 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.49761750 |
| 40 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.49217324 |
| 41 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.46998744 |
| 42 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.45192915 |
| 43 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.45113242 |
| 44 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.44249099 |
| 45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.41918052 |
| 46 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.41540601 |
| 47 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38173211 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.32921814 |
| 49 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.30954618 |
| 50 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.30633250 |
| 51 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.24240564 |
| 52 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18574781 |
| 53 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15445865 |
| 54 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.13914145 |
| 55 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.10194116 |
| 56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08131493 |
| 57 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.06021730 |
| 58 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04349569 |
| 59 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01792248 |
| 60 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01130698 |
| 61 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00656618 |
| 62 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.00503945 |
| 63 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.00456701 |
| 64 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98958202 |
| 65 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.97740679 |
| 66 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.96942308 |
| 67 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95477100 |
| 68 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.94022667 |
| 69 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.93499117 |
| 70 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.92661278 |
| 71 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.92033628 |
| 72 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.92016474 |
| 73 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92012478 |
| 74 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.91740559 |
| 75 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.91636653 |
| 76 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.90903086 |
| 77 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.90166676 |
| 78 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90099432 |
| 79 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.90096345 |
| 80 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.89650203 |
| 81 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88778836 |
| 82 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.88317541 |
| 83 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87900114 |
| 84 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85252785 |
| 85 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.84588967 |
| 86 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.84462407 |
| 87 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83511037 |
| 88 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.82496071 |
| 89 | P300_27268052_Chip-Seq_Bcells_Human | 0.82279227 |
| 90 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.82114276 |
| 91 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.81839184 |
| 92 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81715899 |
| 93 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81557258 |
| 94 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.81472120 |
| 95 | GATA3_26560356_Chip-Seq_TH1_Human | 0.80942543 |
| 96 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.78234894 |
| 97 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.77296198 |
| 98 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.74988747 |
| 99 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.74319879 |
| 100 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.73123859 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 5.61343429 |
| 2 | MP0003763_abnormal_thymus_physiology | 5.22125760 |
| 3 | MP0003436_decreased_susceptibility_to | 4.19121076 |
| 4 | MP0005000_abnormal_immune_tolerance | 3.17618523 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.17103640 |
| 6 | MP0001873_stomach_inflammation | 3.13605516 |
| 7 | MP0001800_abnormal_humoral_immune | 3.00158588 |
| 8 | MP0005387_immune_system_phenotype | 2.95605511 |
| 9 | MP0001790_abnormal_immune_system | 2.95605511 |
| 10 | MP0000685_abnormal_immune_system | 2.94884955 |
| 11 | MP0009333_abnormal_splenocyte_physiolog | 2.88524714 |
| 12 | MP0009785_altered_susceptibility_to | 2.88449405 |
| 13 | MP0002420_abnormal_adaptive_immunity | 2.74323554 |
| 14 | MP0002254_reproductive_system_inflammat | 2.74127853 |
| 15 | MP0001819_abnormal_immune_cell | 2.70068751 |
| 16 | MP0003866_abnormal_defecation | 2.67390402 |
| 17 | MP0002166_altered_tumor_susceptibility | 2.63142676 |
| 18 | MP0002723_abnormal_immune_serum | 2.56254135 |
| 19 | MP0005025_abnormal_response_to | 2.54692031 |
| 20 | MP0003724_increased_susceptibility_to | 2.50571550 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.48005237 |
| 22 | MP0002405_respiratory_system_inflammati | 2.40456853 |
| 23 | MP0002419_abnormal_innate_immunity | 2.32021692 |
| 24 | MP0006082_CNS_inflammation | 2.31017663 |
| 25 | MP0010155_abnormal_intestine_physiology | 2.30001413 |
| 26 | MP0001348_abnormal_lacrimal_gland | 2.29483129 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 2.26351733 |
| 28 | MP0000703_abnormal_thymus_morphology | 2.25962678 |
| 29 | MP0002398_abnormal_bone_marrow | 2.23196655 |
| 30 | MP0005310_abnormal_salivary_gland | 2.22437903 |
| 31 | MP0000716_abnormal_immune_system | 2.10867514 |
| 32 | MP0002722_abnormal_immune_system | 1.88683950 |
| 33 | MP0002006_tumorigenesis | 1.85559162 |
| 34 | MP0000689_abnormal_spleen_morphology | 1.74611267 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.73331970 |
| 36 | MP0001533_abnormal_skeleton_physiology | 1.71939104 |
| 37 | MP0004381_abnormal_hair_follicle | 1.69580769 |
| 38 | MP0004947_skin_inflammation | 1.68633420 |
| 39 | MP0002429_abnormal_blood_cell | 1.63771313 |
| 40 | MP0002277_abnormal_respiratory_mucosa | 1.61715447 |
| 41 | MP0003300_gastrointestinal_ulcer | 1.47674844 |
| 42 | MP0002009_preneoplasia | 1.33316508 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.31806390 |
| 44 | MP0002933_joint_inflammation | 1.30791939 |
| 45 | MP0002396_abnormal_hematopoietic_system | 1.26815197 |
| 46 | MP0003950_abnormal_plasma_membrane | 1.25520549 |
| 47 | MP0001851_eye_inflammation | 1.23783762 |
| 48 | MP0008469_abnormal_protein_level | 1.13662318 |
| 49 | MP0005464_abnormal_platelet_physiology | 1.13583155 |
| 50 | MP0001853_heart_inflammation | 1.13163477 |
| 51 | MP0001346_abnormal_lacrimal_gland | 1.08521459 |
| 52 | MP0005075_abnormal_melanosome_morpholog | 1.05654800 |
| 53 | MP0003303_peritoneal_inflammation | 0.98581366 |
| 54 | MP0002132_abnormal_respiratory_system | 0.97842887 |
| 55 | MP0008057_abnormal_DNA_replication | 0.95228041 |
| 56 | MP0000490_abnormal_crypts_of | 0.94903668 |
| 57 | MP0003448_altered_tumor_morphology | 0.94300968 |
| 58 | MP0002163_abnormal_gland_morphology | 0.93327022 |
| 59 | MP0003045_fibrosis | 0.92137113 |
| 60 | MP0002138_abnormal_hepatobiliary_system | 0.91343498 |
| 61 | MP0002876_abnormal_thyroid_physiology | 0.90751250 |
| 62 | MP0005451_abnormal_body_composition | 0.88509227 |
| 63 | MP0008569_lethality_at_weaning | 0.76421462 |
| 64 | MP0009764_decreased_sensitivity_to | 0.76326457 |
| 65 | MP0001919_abnormal_reproductive_system | 0.76275003 |
| 66 | MP0005166_decreased_susceptibility_to | 0.73824173 |
| 67 | MP0002019_abnormal_tumor_incidence | 0.69814440 |
| 68 | MP0008877_abnormal_DNA_methylation | 0.69327607 |
| 69 | MP0003191_abnormal_cellular_cholesterol | 0.68440309 |
| 70 | MP0003806_abnormal_nucleotide_metabolis | 0.68180536 |
| 71 | MP0003786_premature_aging | 0.68066392 |
| 72 | MP0002090_abnormal_vision | 0.66750104 |
| 73 | MP0000372_irregular_coat_pigmentation | 0.66380237 |
| 74 | MP0005645_abnormal_hypothalamus_physiol | 0.63944638 |
| 75 | MP0003690_abnormal_glial_cell | 0.63858526 |
| 76 | MP0009763_increased_sensitivity_to | 0.63361266 |
| 77 | MP0005390_skeleton_phenotype | 0.63123677 |
| 78 | MP0002998_abnormal_bone_remodeling | 0.62289659 |
| 79 | MP0001663_abnormal_digestive_system | 0.61981478 |
| 80 | MP0008058_abnormal_DNA_repair | 0.61685790 |
| 81 | MP0002693_abnormal_pancreas_physiology | 0.61594092 |
| 82 | MP0000858_altered_metastatic_potential | 0.60758861 |
| 83 | MP0005167_abnormal_blood-brain_barrier | 0.55168445 |
| 84 | MP0002136_abnormal_kidney_physiology | 0.54646692 |
| 85 | MP0000249_abnormal_blood_vessel | 0.51179558 |
| 86 | MP0000604_amyloidosis | 0.51087179 |
| 87 | MP0000015_abnormal_ear_pigmentation | 0.49650611 |
| 88 | MP0000609_abnormal_liver_physiology | 0.48706337 |
| 89 | MP0009840_abnormal_foam_cell | 0.46856535 |
| 90 | MP0005379_endocrine/exocrine_gland_phen | 0.46395197 |
| 91 | MP0005647_abnormal_sex_gland | 0.46276590 |
| 92 | MP0003795_abnormal_bone_structure | 0.43108473 |
| 93 | MP0003075_altered_response_to | 0.42642100 |
| 94 | MP0001502_abnormal_circadian_rhythm | 0.41533193 |
| 95 | MP0008004_abnormal_stomach_pH | 0.39979322 |
| 96 | MP0008961_abnormal_basal_metabolism | 0.39661037 |
| 97 | MP0004883_abnormal_blood_vessel | 0.39206655 |
| 98 | MP0009643_abnormal_urine_homeostasis | 0.38799758 |
| 99 | MP0002736_abnormal_nociception_after | 0.36594007 |
| 100 | MP0000920_abnormal_myelination | 0.36075523 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Autoimmune hemolytic anemia (HP:0001890) | 8.24127496 |
| 2 | Autoimmune thrombocytopenia (HP:0001973) | 6.95074727 |
| 3 | Visual hallucinations (HP:0002367) | 5.99521172 |
| 4 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 5.87963128 |
| 5 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.71333314 |
| 6 | T lymphocytopenia (HP:0005403) | 5.68194340 |
| 7 | Abnormality of T cell number (HP:0011839) | 5.32323477 |
| 8 | Abnormality of T cells (HP:0002843) | 5.23907652 |
| 9 | Increased cerebral lipofuscin (HP:0011813) | 5.04041965 |
| 10 | Stomatitis (HP:0010280) | 5.03749719 |
| 11 | Abnormality of T cell physiology (HP:0011840) | 4.79584586 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.62967549 |
| 13 | Eczematoid dermatitis (HP:0000976) | 4.50922250 |
| 14 | Recurrent viral infections (HP:0004429) | 4.31187528 |
| 15 | Prostate neoplasm (HP:0100787) | 4.30742499 |
| 16 | Lymphopenia (HP:0001888) | 4.20298672 |
| 17 | Testicular atrophy (HP:0000029) | 3.93821045 |
| 18 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.87981521 |
| 19 | Gastrointestinal infarctions (HP:0005244) | 3.70783898 |
| 20 | Vasculitis (HP:0002633) | 3.59348770 |
| 21 | Myositis (HP:0100614) | 3.58491721 |
| 22 | Recurrent fungal infections (HP:0002841) | 3.54658649 |
| 23 | Tetraparesis (HP:0002273) | 3.50948088 |
| 24 | IgG deficiency (HP:0004315) | 3.47251173 |
| 25 | Severe combined immunodeficiency (HP:0004430) | 3.41671536 |
| 26 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.34419765 |
| 27 | Keratoconjunctivitis (HP:0001096) | 3.30991700 |
| 28 | Recurrent cutaneous fungal infections (HP:0011370) | 3.28233191 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.28233191 |
| 30 | Retrobulbar optic neuritis (HP:0100654) | 3.25055272 |
| 31 | Optic neuritis (HP:0100653) | 3.25055272 |
| 32 | IgM deficiency (HP:0002850) | 3.18443294 |
| 33 | Abnormality of the prostate (HP:0008775) | 3.12757656 |
| 34 | Lymphoma (HP:0002665) | 3.07503171 |
| 35 | Orchitis (HP:0100796) | 3.04183080 |
| 36 | Dyschromatopsia (HP:0007641) | 3.02927106 |
| 37 | Abnormality of macrophages (HP:0004311) | 2.96038425 |
| 38 | Mediastinal lymphadenopathy (HP:0100721) | 2.87914100 |
| 39 | Increased IgM level (HP:0003496) | 2.87573248 |
| 40 | Recurrent abscess formation (HP:0002722) | 2.87557000 |
| 41 | Pustule (HP:0200039) | 2.87105142 |
| 42 | Recurrent bacterial skin infections (HP:0005406) | 2.86917361 |
| 43 | Meningitis (HP:0001287) | 2.78960976 |
| 44 | Granulocytopenia (HP:0001913) | 2.78403206 |
| 45 | Encephalitis (HP:0002383) | 2.77832965 |
| 46 | Abnormality of eosinophils (HP:0001879) | 2.77676004 |
| 47 | Increased IgE level (HP:0003212) | 2.74175872 |
| 48 | Combined immunodeficiency (HP:0005387) | 2.73824760 |
| 49 | Eosinophilia (HP:0001880) | 2.67790415 |
| 50 | Chronic obstructive pulmonary disease (HP:0006510) | 2.67595600 |
| 51 | Obstructive lung disease (HP:0006536) | 2.67595600 |
| 52 | Chronic diarrhea (HP:0002028) | 2.67592867 |
| 53 | Spastic diplegia (HP:0001264) | 2.65230261 |
| 54 | Leukocytosis (HP:0001974) | 2.64958831 |
| 55 | Recurrent bronchitis (HP:0002837) | 2.63194156 |
| 56 | Keratoconjunctivitis sicca (HP:0001097) | 2.48387717 |
| 57 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.46866886 |
| 58 | Chest pain (HP:0100749) | 2.44736686 |
| 59 | Panhypogammaglobulinemia (HP:0003139) | 2.42240989 |
| 60 | Recurrent skin infections (HP:0001581) | 2.42198052 |
| 61 | Papilloma (HP:0012740) | 2.40390181 |
| 62 | Verrucae (HP:0200043) | 2.40390181 |
| 63 | Pulmonary infiltrates (HP:0002113) | 2.38966673 |
| 64 | Spontaneous hematomas (HP:0007420) | 2.38914673 |
| 65 | Malnutrition (HP:0004395) | 2.31957880 |
| 66 | Abnormality of B cell number (HP:0010975) | 2.31790732 |
| 67 | Central scotoma (HP:0000603) | 2.23314926 |
| 68 | B lymphocytopenia (HP:0010976) | 2.19677392 |
| 69 | Thyroiditis (HP:0100646) | 2.16394083 |
| 70 | Abnormality of purine metabolism (HP:0004352) | 2.13907366 |
| 71 | Hypochromic anemia (HP:0001931) | 2.13113454 |
| 72 | Prolonged bleeding time (HP:0003010) | 2.10532610 |
| 73 | Parakeratosis (HP:0001036) | 2.10278932 |
| 74 | Hypochromic microcytic anemia (HP:0004840) | 2.09897207 |
| 75 | Asplenia (HP:0001746) | 2.09794600 |
| 76 | Keratitis (HP:0000491) | 2.05825928 |
| 77 | Basal cell carcinoma (HP:0002671) | 2.03308479 |
| 78 | Progressive external ophthalmoplegia (HP:0000590) | 2.01740706 |
| 79 | Joint swelling (HP:0001386) | 1.98071405 |
| 80 | Hemoptysis (HP:0002105) | 1.97018831 |
| 81 | Hypergammaglobulinemia (HP:0010702) | 1.95209825 |
| 82 | Gangrene (HP:0100758) | 1.93037986 |
| 83 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.92702400 |
| 84 | Pulmonary embolism (HP:0002204) | 1.88091634 |
| 85 | Urticaria (HP:0001025) | 1.86910991 |
| 86 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.85691499 |
| 87 | Gingivitis (HP:0000230) | 1.82781138 |
| 88 | Abnormality of male internal genitalia (HP:0000022) | 1.81500064 |
| 89 | Amaurosis fugax (HP:0100576) | 1.78741535 |
| 90 | Hypoproteinemia (HP:0003075) | 1.77550735 |
| 91 | Congenital stationary night blindness (HP:0007642) | 1.77004999 |
| 92 | Acute hepatic failure (HP:0006554) | 1.73347387 |
| 93 | Global brain atrophy (HP:0002283) | 1.72995602 |
| 94 | Recurrent lower respiratory tract infections (HP:0002783) | 1.70447166 |
| 95 | Arterial thrombosis (HP:0004420) | 1.70264802 |
| 96 | Neutropenia (HP:0001875) | 1.70227046 |
| 97 | Inflammation of the large intestine (HP:0002037) | 1.70074597 |
| 98 | Papilledema (HP:0001085) | 1.66968850 |
| 99 | Recurrent sinusitis (HP:0011108) | 1.66771718 |
| 100 | Teleangiectasia of the skin (HP:0100585) | 1.64763637 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 6.82839901 |
| 2 | TXK | 5.74091701 |
| 3 | ZAP70 | 2.88685406 |
| 4 | TAOK3 | 2.79553671 |
| 5 | KDR | 2.78113097 |
| 6 | MAP3K11 | 2.71670040 |
| 7 | FES | 2.54672986 |
| 8 | TESK2 | 2.28590858 |
| 9 | ITK | 2.28243378 |
| 10 | PASK | 2.26793259 |
| 11 | BTK | 2.24259510 |
| 12 | IKBKE | 2.15773278 |
| 13 | RIPK4 | 2.13670159 |
| 14 | GRK6 | 2.11399104 |
| 15 | MAP3K12 | 2.11094140 |
| 16 | CSK | 2.00167443 |
| 17 | EPHB1 | 1.76042590 |
| 18 | TBK1 | 1.74437567 |
| 19 | LCK | 1.66184947 |
| 20 | IKBKB | 1.63996361 |
| 21 | BMPR2 | 1.61886654 |
| 22 | CAMKK1 | 1.60378157 |
| 23 | CAMKK2 | 1.54993382 |
| 24 | SYK | 1.54122483 |
| 25 | MAP3K14 | 1.51826064 |
| 26 | JAK3 | 1.51237870 |
| 27 | MAP3K13 | 1.48937409 |
| 28 | TNK2 | 1.44549768 |
| 29 | EPHA3 | 1.34297543 |
| 30 | TEC | 1.34089250 |
| 31 | TYK2 | 1.33873722 |
| 32 | PRPF4B | 1.33580445 |
| 33 | HCK | 1.29304121 |
| 34 | BLK | 1.26739668 |
| 35 | NLK | 1.19400296 |
| 36 | LYN | 1.18378407 |
| 37 | JAK1 | 1.09601487 |
| 38 | IRAK4 | 1.09594059 |
| 39 | NEK1 | 1.08132367 |
| 40 | FGFR4 | 1.04136374 |
| 41 | MARK3 | 1.03450147 |
| 42 | MAP3K1 | 0.98869725 |
| 43 | CDK12 | 0.95871265 |
| 44 | STK10 | 0.93852028 |
| 45 | PRKCQ | 0.87661933 |
| 46 | PIM1 | 0.86644723 |
| 47 | JAK2 | 0.81643311 |
| 48 | MAPK15 | 0.76328041 |
| 49 | LRRK2 | 0.73160799 |
| 50 | HIPK2 | 0.71168421 |
| 51 | GRK7 | 0.70516577 |
| 52 | FGFR3 | 0.67489413 |
| 53 | PKN2 | 0.65470095 |
| 54 | PTK6 | 0.65430925 |
| 55 | SIK3 | 0.64107997 |
| 56 | TAOK1 | 0.62646790 |
| 57 | STK16 | 0.61396808 |
| 58 | CSF1R | 0.61390848 |
| 59 | MAP2K3 | 0.59608254 |
| 60 | PDK1 | 0.55166938 |
| 61 | MAP3K5 | 0.52611532 |
| 62 | GRK5 | 0.51402163 |
| 63 | FYN | 0.51285229 |
| 64 | MAPK7 | 0.50837919 |
| 65 | FGR | 0.49392594 |
| 66 | TAOK2 | 0.48823463 |
| 67 | TYRO3 | 0.46836096 |
| 68 | RPS6KB1 | 0.44520990 |
| 69 | MAPK12 | 0.44120330 |
| 70 | TGFBR2 | 0.43780154 |
| 71 | SCYL2 | 0.41176431 |
| 72 | TRIB3 | 0.40592158 |
| 73 | BRD4 | 0.40409774 |
| 74 | PRKD2 | 0.39459429 |
| 75 | MAP3K3 | 0.37883020 |
| 76 | CDK19 | 0.34162202 |
| 77 | TESK1 | 0.33562711 |
| 78 | PRKCH | 0.31333701 |
| 79 | CLK1 | 0.30771307 |
| 80 | IRAK1 | 0.29222720 |
| 81 | MAPK3 | 0.28536081 |
| 82 | MAP2K2 | 0.27938233 |
| 83 | MAPK11 | 0.26822962 |
| 84 | IGF1R | 0.26551562 |
| 85 | MAPKAPK2 | 0.26000462 |
| 86 | GSK3A | 0.25043576 |
| 87 | PDGFRB | 0.24414685 |
| 88 | ADRBK2 | 0.24035932 |
| 89 | TRPM7 | 0.22814125 |
| 90 | MAP3K7 | 0.22435713 |
| 91 | CAMK2D | 0.18539121 |
| 92 | PRKCD | 0.18444649 |
| 93 | CDK4 | 0.18100023 |
| 94 | RPS6KC1 | 0.17723110 |
| 95 | RPS6KL1 | 0.17723110 |
| 96 | SMG1 | 0.17577128 |
| 97 | WNK1 | 0.17312828 |
| 98 | CHUK | 0.17105385 |
| 99 | ERN1 | 0.16333326 |
| 100 | MYLK | 0.16179615 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.17387678 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.70782037 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.93486595 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.92534744 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.79151665 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.64311010 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.58356956 |
| 8 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.46180521 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.33054816 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.24770051 |
| 11 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.23788718 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.10686587 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.07729456 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.06217309 |
| 15 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.01977626 |
| 16 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.91579523 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.90047043 |
| 18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.74739002 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.70989243 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.68766102 |
| 21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.67566009 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.63613600 |
| 23 | Viral myocarditis_Homo sapiens_hsa05416 | 1.62956184 |
| 24 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.61974677 |
| 25 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.56529196 |
| 26 | Leishmaniasis_Homo sapiens_hsa05140 | 1.54605551 |
| 27 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.43472811 |
| 28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.39391452 |
| 29 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.39214905 |
| 30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.29888793 |
| 31 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.27559981 |
| 32 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.25644233 |
| 33 | Proteasome_Homo sapiens_hsa03050 | 1.23322059 |
| 34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.20187469 |
| 35 | Ribosome_Homo sapiens_hsa03010 | 1.19721885 |
| 36 | Malaria_Homo sapiens_hsa05144 | 1.19477849 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 1.13866842 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.11062140 |
| 39 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.09102586 |
| 40 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.08972861 |
| 41 | HTLV-I infection_Homo sapiens_hsa05166 | 1.07508437 |
| 42 | Influenza A_Homo sapiens_hsa05164 | 1.02398059 |
| 43 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.95707908 |
| 44 | Legionellosis_Homo sapiens_hsa05134 | 0.92238329 |
| 45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.91712362 |
| 46 | Asthma_Homo sapiens_hsa05310 | 0.90000146 |
| 47 | Phototransduction_Homo sapiens_hsa04744 | 0.89363054 |
| 48 | Spliceosome_Homo sapiens_hsa03040 | 0.86821347 |
| 49 | Tuberculosis_Homo sapiens_hsa05152 | 0.85884446 |
| 50 | Apoptosis_Homo sapiens_hsa04210 | 0.84648480 |
| 51 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.82842119 |
| 52 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.82615447 |
| 53 | Pertussis_Homo sapiens_hsa05133 | 0.80415651 |
| 54 | Shigellosis_Homo sapiens_hsa05131 | 0.79462207 |
| 55 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.79077402 |
| 56 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.73286443 |
| 57 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.72149688 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 0.71011068 |
| 59 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.68131640 |
| 60 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.66433647 |
| 61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.65686711 |
| 62 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.57791329 |
| 63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57762216 |
| 64 | Platelet activation_Homo sapiens_hsa04611 | 0.56446276 |
| 65 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.56336644 |
| 66 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.54569619 |
| 67 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.49911441 |
| 68 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.48172739 |
| 69 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.47606859 |
| 70 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47549684 |
| 71 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.39805007 |
| 72 | Endocytosis_Homo sapiens_hsa04144 | 0.39722123 |
| 73 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.37861428 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36923020 |
| 75 | Colorectal cancer_Homo sapiens_hsa05210 | 0.33472816 |
| 76 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.32016047 |
| 77 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.31119395 |
| 78 | Salmonella infection_Homo sapiens_hsa05132 | 0.30081882 |
| 79 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.29735049 |
| 80 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.29597952 |
| 81 | RNA degradation_Homo sapiens_hsa03018 | 0.29569305 |
| 82 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.28909817 |
| 83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.28313305 |
| 84 | Homologous recombination_Homo sapiens_hsa03440 | 0.27506019 |
| 85 | Parkinsons disease_Homo sapiens_hsa05012 | 0.26789326 |
| 86 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.25467795 |
| 87 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.24921401 |
| 88 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.23805859 |
| 89 | Phagosome_Homo sapiens_hsa04145 | 0.22096890 |
| 90 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.20197511 |
| 91 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.18640919 |
| 92 | Mineral absorption_Homo sapiens_hsa04978 | 0.17287749 |
| 93 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.17112312 |
| 94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.16954219 |
| 95 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.16542676 |
| 96 | Alzheimers disease_Homo sapiens_hsa05010 | 0.15987775 |
| 97 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.15493852 |
| 98 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.13929506 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.12798637 |
| 100 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.12471016 |

